Cite
HARVARD Citation
Cassidy, R. et al. (2017). Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base. Cancer. 123 (5), pp. 783-793. [Online].